Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $124
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an 'Outperform' rating on US Physical Therapy (NYSE:USPH) and raised the price target from $116 to $124.
August 14, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
US Physical Therapy's price target has been raised from $116 to $124 by Barrington Research, which maintains an 'Outperform' rating on the stock.
The raised price target and maintained 'Outperform' rating by Barrington Research indicates a positive outlook for US Physical Therapy. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100